The Division of Hematology and Medical Oncology provides its subspecialty residents a broad-based educational opportunity in all aspects of solid tumors, and malignant and nonmalignant hematologic disorders, as well as bone marrow and peripheral stem cell transplantation. It is a three-year program with an emphasis on inpatient and outpatient care, as well as developing the teaching and research skills of the trainees.
Entrance into the program requires three years of internal medicine residency training at a U.S. institution with resulting board eligibility in internal medicine. After completing the program, trainees are board eligible in both hematology and medical oncology by the American Board of Internal Medicine.
Our physicians' interests include breast cancer, lymphomas, leukemias, head and neck tumors, GI malignancies, lung cancer, colon cancer, prostate cancer, sarcomas, melanomas, myeloma, autoimmune diseases, and both autologous and allogeneic bone marrow and peripheral stem cell transplantation, as well as thrombotic and bleeding disorders.
Our hemostasis and thrombotic disorders program includes the Regional Hemophilia Treatment Center and Coagulation Reference Laboratory. Our transplant team uses resources such as the National Marrow Donor Program, International Bone Marrow Transplant Registry, and Autologous Blood and Marrow Transplant Registry. Our trainees also have an opportunity to learn management of conditions related to transplantation, such as graft versus host disease and immune system dysfunction.